| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |